利维爱、米非司酮在绝经后妇女取环中的应用观察-现代医学

利维爱、米非司酮在绝经后妇女取环中的应用观察

单位：上海市普陀区妇婴保健院

分类号：

出版年·卷·期（页码）：2013·41·第五期（319-321）

摘要：

目的探讨利维爱、米非司酮在绝经后妇女取环中宫颈准备的效果。方法将210例绝经后妇女要求取环者，随机分为三组，每组各70例。A组：取环前一周开始口服利维爱2.5mg，1次/天×7天，7天后手术。B组：取环前一周开始口服米非司酮25mg，1次/天×4天，7天后手术。C组：直接取环。分析三组取环中不同药物应用的临床效果观察。结果 A，B两组在宫颈软化，取环效果，手术时间方面与C组比较差异均有统计学意义（P＜0.01），A，B两组之间各项比较差异无统计学意义（P＞0.05）。结论利维爱与米非司酮用于绝经后妇女取环，均可提高手术成功率。

Objective To explore Livial, Mifepristone in postmenopausal women take the IUD removal cervical preparation effect. Methods Two hundred and ten cases of post-menopausal women who request for IUD were randomly allocated to three groups,each group of each seventy cases. A group:Take Livial 2.5mg qd po ×7 days, a week before began to IUD,operation in seven days. B group:Take Mifepristone 25 mg qd po ×4 days, a week before began to IUD,operation in seven days. C group: directly for IUD. Analysis of the three groups take the Intrauterine device （IUD ） of the application of different drugs to observe clinical effect. Result A,B two groups in cervical softening, for IUD effect, operation time and comparing group C were statistically significant(P＜0.01), with no significant difference between A,B groups(P＞0.05). Conclusion Livial, Mifepristone used for postmenopausal for IUD, all can improve the success rate.

参考文献：

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录